Comparison of efficacy and safety of nab-paclitaxel and oxaliplatin + S-1 and standard S-1 and oxaliplatin chemotherapy regimens for treatment of gastric cancer
In comparison to the SOX regimen, the P-SOX regimen demonstrates improved short-term and long-term efficacy with tolerable adverse reactions. It is anticipated that the P-SOX regimen will emerge as a first-line chemotherapy option for GC. Patients with GC who receive effective perioperative chemotherapy (Response Evaluation Criteria in Solid Tumors 1.1, Tumor Regression Grade), have a tumor diameter ≤ 2cm, exhibit high degree of differentiation, and are at an early cTNM stage show better prognosis.
Authors
- Gong-Ping Wang
- Baojia Cai (ORCID: https://orcid.org/0000-0002-7970-2667)
- Jingjing Xiao (ORCID: https://orcid.org/0000-0001-5020-638X)
- Can Guo
- Feng Long (ORCID: https://orcid.org/0000-0001-6473-8037)
- Yan Song (ORCID: https://orcid.org/0000-0002-5955-0205)
- Yuandong Li (ORCID: https://orcid.org/0000-0003-1093-7625)
- Bo-Hao Lin
- Ting Pan
- Peng-Jie Yu
- Yi-Cong Wang
Institutions
- Northwest University (CN)
- Qinghai University Affiliated Hospital (CN)
- Luoyang Orthopedic-Traumatological Hospital of Henan Province (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2024-09-27
- DOI
- https://doi.org/10.4240/wjgs.v16.i10.3224
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00